- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02927938
Leukemia Stem Cell Detection in Acute Myeloid Leukemia
연구 개요
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28204
- Levine Cancer Institute
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Must have previously signed the specimen procurement protocol consent associated with the leukemia stem cell assay ("Step 1 informed consent") prior to starting AML therapy.
- Age 18 years and older
- New diagnosis of AML, other than APL, confirmed by bone marrow aspirate/biopsy and reviewed by an institutional hematopathologist
- Completion of induction therapy, as defined by the Investigator and post-induction bone marrow biopsy.
Exclusion Criteria:
- Any debilitating medical or psychiatric illness that would preclude ability to follow study procedures.
- Indeterminate leukemia stem cell assay results at diagnosis.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
다른: Evaluable Cohort - Transplant Arm
Other - Standard of Care Consolidation (HCT) Enrolled subjects that will contribute to the population of subjects who are evaluable for the primary and secondary objectives. This will not include any subjects who end up in either observational cohort. To be included in the evaluable cohort, the subject must meet the following requirements:
|
Allogeneic HCT
다른 이름들:
|
다른: Evaluable Cohort - Consolidation Chemo Arm
Other - Standard of Care Consolidation (cytarabine-based chemo) Enrolled subjects that will contribute to the population of subjects who are evaluable for the primary and secondary objectives. This will not include any subjects who end up in either observational cohort. To be included in the evaluable cohort, the subject must meet the following requirements:
|
Cytarabine-based consolidation chemotherapy
다른 이름들:
|
간섭 없음: Observational Cohort 1
Enrolled subjects who do not achieve a CR to induction therapy, regardless of diagnostic phenotype.
Following completion of induction therapy and remission bone marrow aspirate, if a subject is determined to not have achieved a complete remission to induction therapy, he or she would be included in observational cohort 1.
|
|
간섭 없음: Observational Cohort 2
Enrolled subjects who achieve a CR to induction therapy but meet one or more of the following criteria:
Final investigator determination of fit-ness can occur at any time until the start of consolidation therapy. HMA-based induction subjects will not receive consolidation cytarabine-based chemotherapy as part of the evaluable cohort if they do not receive HCT. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
2 Year Relapse Free Survival (RFS)
기간: 2 years
|
Comparison of 2 year RFS in patient with detectable LSCs in the marrow at the end of consolidation to the 2 year RFS of patients without detectable LSCs.
IWG Criteria (Cheson 2003) was utilized to classify relapse, with relapse defined as ≥ 5% blasts in the marrow or peripheral blood, extramedullary disease, or disease presence determined by a physician upon clinical assessment.
|
2 years
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Michael Grunwald, M.D., Wake Forest University Health Sciences
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- LCI-HEM-AML-SCD-001
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Allogeneic HCT에 대한 임상 시험
-
University of South CarolinaDuke University; Kilimanjaro Christian Medical Centre, Tanzania완전한
-
The First Affiliated Hospital of Soochow UniversityZhejiang University; The Second People's Hospital of Huai'an; Soochow Hopes Hematology Hospital 그리고 다른 협력자들완전한
-
The First Affiliated Hospital of Soochow UniversityFirst Affiliated Hospital Xi'an Jiaotong University; Ruijin Hospital; Wuhan Union Hospital... 그리고 다른 협력자들모병
-
Centers for Disease Control and PreventionEducation Development Center, Inc.; Callen-Lorde Community Health Center; Hispanic AIDS Forum...완전한
-
Centers for Disease Control and PreventionUniversity of Miami; Nova Southeastern University; DePaul University완전한
-
Joanne Kurtzberg, MDThe Marcus Foundation완전한
-
Joanne Kurtzberg, MDDuke Clinical and Translational Science Institute (CTSI), part of the NIH Clinical and...완전한
-
John MascarenhasNational Cancer Institute (NCI); Novartis; Incyte Corporation; Myeloproliferative Disorders-Research...종료됨
-
Masonic Cancer Center, University of Minnesota모집하지 않고 적극적으로